ES2523401T3 - Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona - Google Patents

Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona Download PDF

Info

Publication number
ES2523401T3
ES2523401T3 ES12000613.5T ES12000613T ES2523401T3 ES 2523401 T3 ES2523401 T3 ES 2523401T3 ES 12000613 T ES12000613 T ES 12000613T ES 2523401 T3 ES2523401 T3 ES 2523401T3
Authority
ES
Spain
Prior art keywords
hydroxy
thiazolidin
benc
iliden
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12000613.5T
Other languages
English (en)
Spanish (es)
Inventor
Stefan Abele
Martin Bolli
Gunther Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actelion Pharmaceuticals Ltd
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2523401T3 publication Critical patent/ES2523401T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES12000613.5T 2006-11-23 2007-11-22 Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona Active ES2523401T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2006054409 2006-11-23
WOPCT/IB2006/054409 2006-11-23

Publications (1)

Publication Number Publication Date
ES2523401T3 true ES2523401T3 (es) 2014-11-25

Family

ID=39316391

Family Applications (2)

Application Number Title Priority Date Filing Date
ES12000613.5T Active ES2523401T3 (es) 2006-11-23 2007-11-22 Intermedios de un nuevo procedimiento para la preparación de derivados de 5-benciliden-2-alquilimino-3- feniltiazolidin-4-ona
ES07849225T Active ES2410793T3 (es) 2006-11-23 2007-11-22 Nuevo procedimiento para la preparación de derivados de 2-imino-tiazolidin-4-ona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES07849225T Active ES2410793T3 (es) 2006-11-23 2007-11-22 Nuevo procedimiento para la preparación de derivados de 2-imino-tiazolidin-4-ona

Country Status (13)

Country Link
US (1) US8263780B2 (enExample)
EP (2) EP2094676B1 (enExample)
JP (1) JP4669564B2 (enExample)
KR (1) KR101255879B1 (enExample)
CN (2) CN101541772B (enExample)
AU (1) AU2007323042B2 (enExample)
CA (1) CA2669069C (enExample)
DK (2) DK2489662T3 (enExample)
ES (2) ES2523401T3 (enExample)
IL (1) IL198847A (enExample)
MX (1) MX2009005048A (enExample)
TW (1) TWI460166B (enExample)
WO (1) WO2008062376A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
US7435828B2 (en) 2003-11-21 2008-10-14 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
WO2009115954A1 (en) * 2008-03-17 2009-09-24 Actelion Pharmaceuticals Ltd Dosing regimen for a selective s1p1 receptor agonist
GB0819182D0 (en) 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms
SMT202000298T1 (it) 2012-08-17 2020-07-08 Actelion Pharmaceuticals Ltd Processo per la produzione di (2z,5z)-5-(3-cloro-4((r)-2,3-diidrossipropossi) benziliden)-2-(propilimmino)-3-(o-tolil)tiazolidin-4-one e intermedio usato in detto processo
MA41139B1 (fr) 2014-12-11 2026-02-27 Laboratoires Juvise Pharmaceuticals Combinaison pharmaceutique comprenant du ponesimod et son utilisation dans le traitement de la sclérose en plaque
DK3256125T3 (da) 2014-12-11 2022-03-21 Actelion Pharmaceuticals Ltd Doseringsregimen for ponesimod, en selektiv s1p1-receptoragonist
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود
WO2019060147A1 (en) * 2017-09-19 2019-03-28 Teva Pharmaceuticals Usa, Inc. NEW CRYSTALLINE POLYMORPHE FROM PONESIMOD
US11014940B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Thiazolidinone and oxazolidinone compounds and formulations
US11186556B1 (en) 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
US11013723B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms of a thiazolidinone compound, compositions and methods of use thereof
US11014897B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof
WO2021005081A1 (de) * 2019-07-10 2021-01-14 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-(phenylimino)-1,3-thiazolidin-4-onen
BR112022000188A2 (pt) * 2019-07-10 2022-02-22 Bayer Ag Método para a preparação de 2-(fenilimino)-1,3-tiazolidin-4-onas
TW202131921A (zh) 2019-10-31 2021-09-01 瑞士商愛杜西亞製藥有限公司 Cxcr7拮抗劑與s1p1受體調節劑之組合
KR20200019639A (ko) 2020-01-30 2020-02-24 전대연 만남의 스마트 도착시스템
WO2021165187A1 (de) * 2020-02-18 2021-08-26 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-(phenylimino)-3-alkyl-1,3-thiazolidin-4-onen
WO2023022896A1 (en) 2021-08-17 2023-02-23 Teva Czech Industries S.R.O Polymorphs of ponesimod
EP4212156A1 (en) 2022-01-13 2023-07-19 Abivax Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator
WO2023152691A1 (en) * 2022-02-10 2023-08-17 Metrochem Api Pvt Ltd Process for the preparation of ponesimod and its intermediates thereof
CN117924210B (zh) * 2024-01-22 2026-04-03 赣南师范大学 一种2-亚氨基噻唑烷-4-酮类化合物的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077402A (en) * 1954-12-06 1963-02-12 Polaroid Corp Photographic color processes, products, and compositions
NL270002A (enExample) * 1960-10-08
OA03835A (fr) * 1970-07-17 1971-12-24 Rhone Poulenc Sa Nouveaux dérivés de la thiazolidine, leur préparation et les compositions qui les contiennent.
EP0526598B1 (en) * 1990-04-27 1996-12-18 Orion-Yhtymà„ Oy New pharmacologically active catechol derivatives
TW221689B (enExample) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
AU669427B2 (en) * 1993-02-26 1996-06-06 Otsuka Pharmaceutical Co., Ltd. Thiazole or imidazole derivatives as maillard reaction inhibbitors
KR960022486A (ko) 1994-12-29 1996-07-18 김준웅 신규 티아졸리딘-4-온 유도체
US6353006B1 (en) * 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
CN1247553C (zh) 1999-09-14 2006-03-29 盐野义制药株式会社 2－亚氨基－1,3－噻嗪衍生物
KR100608416B1 (ko) * 1999-11-12 2006-08-02 후지모토 쿄다이 가부시키가이샤 2-(ｎ-시아노이미노)티아졸리딘-4-온 유도체
US20050019825A9 (en) * 2002-03-15 2005-01-27 Qing Dong Common ligand mimics: pseudothiohydantoins
EA011807B1 (ru) 2002-07-10 2009-06-30 Лаборатуар Сероно Са Азолидинонвинильные производные конденсированного бензола
GB0217152D0 (en) 2002-07-24 2002-09-04 Novartis Ag Organic compounds
JP2006509765A (ja) * 2002-11-22 2006-03-23 スミスクライン・ビーチャム・コーポレイション 新規化合物
US20040167192A1 (en) * 2003-01-16 2004-08-26 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
US7435828B2 (en) * 2003-11-21 2008-10-14 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
WO2005082901A1 (en) * 2004-02-25 2005-09-09 Smithkline Beecham Corporation Novel chemical compounds
WO2006094233A1 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. N,n'-dicyclic isothiourea sirtuin modulators
WO2009115954A1 (en) * 2008-03-17 2009-09-24 Actelion Pharmaceuticals Ltd Dosing regimen for a selective s1p1 receptor agonist
GB0819182D0 (en) * 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms

Also Published As

Publication number Publication date
WO2008062376A2 (en) 2008-05-29
CA2669069A1 (en) 2008-05-29
KR20090081009A (ko) 2009-07-27
WO2008062376A3 (en) 2008-07-10
JP4669564B2 (ja) 2011-04-13
CA2669069C (en) 2015-02-17
US8263780B2 (en) 2012-09-11
US20100317867A1 (en) 2010-12-16
AU2007323042A1 (en) 2008-05-29
KR101255879B1 (ko) 2013-04-17
JP2010510976A (ja) 2010-04-08
TWI460166B (zh) 2014-11-11
BRPI0718986A2 (pt) 2014-02-11
EP2094676B1 (en) 2013-04-10
DK2489662T3 (da) 2014-10-20
CN101541772B (zh) 2013-04-17
IL198847A (en) 2015-07-30
EP2094676A2 (en) 2009-09-02
DK2094676T3 (da) 2013-06-10
MX2009005048A (es) 2009-05-25
US20110201821A2 (en) 2011-08-18
AU2007323042B2 (en) 2012-12-20
TW200831474A (en) 2008-08-01
EP2489662A1 (en) 2012-08-22
CN101541772A (zh) 2009-09-23
ES2410793T3 (es) 2013-07-03
IL198847A0 (en) 2010-02-17
EP2489662B1 (en) 2014-08-06
CN103087004A (zh) 2013-05-08

Similar Documents

Publication Publication Date Title
ES2410793T3 (es) Nuevo procedimiento para la preparación de derivados de 2-imino-tiazolidin-4-ona
US8912340B2 (en) Process for the preparation of 2-imino-thiazolidin-4-one derivatives
PT1689726E (pt) Derivados de 5-(benz-(z)-ilideno)-tiazolidin-4-ona como agentes imunossupressores
JPH04234864A (ja) ２−クロロチアゾール類の製造方法
EA029030B1 (ru) Пептидилнитрильные соединения в качестве ингибиторов дипептидилпептидазы i
WO1992005165A1 (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
JP2018527324A (ja) ガンを処置するのに使用するための置換疎水性ベンゼンスルホンアミドチアゾール化合物
LV10437B (en) Substituted 1-(1h-imidazole-4-yl)alkylbenzamides
JPS6018653B2 (ja) 新規な２，６−ジ置換２−フエニルイミノ−イミダゾリジンおよびその酸付加塩の製造方法
WO2019170051A1 (zh) 一种DACOs类NNRTIs氨基酸酯衍生物、其制备方法、药物组合物及应用
EP3192792B1 (en) Aminosulfonyl-based compounds, preparation method therefor and use thereof
CN101456862B (zh) 含有吡唑并嘧啶酮的苯基胍衍生物、其药物组合物及其制备方法和用途
HU210683B (en) Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
JP2006500409A5 (enExample)
WO2001030771A1 (en) Thiazolidinedione derivatives
JPH10237028A (ja) Ｎｏｓ阻害作用を有する芳香族アミン誘導体
IE58684B1 (en) Aminobenzamide derivatives
LT3211B (en) Novel derivatives of hydroxyanthranilic acid, methods for their preparation and the use thereof
ES2443538B1 (es) Compuestos beta-lactámicos inhibidores de APAF1
MXPA06005590A (en) 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
BRPI0718986B1 (pt) Processo para a preparação de um composto
JPS5850229B2 (ja) 新規なピリド〔２，３−ｄ〕ピリミジン誘導体の製造体